Last reviewed · How we verify
Evaluating a Digital Tool for Supporting Breast Cancer Patients (ADAPT)
This is a prospective randomised controlled trial that aims to understand the impact of the OWise breast cancer digital tool in newly diagnosed breast cancer patients. Half the patients will receive the digital tool and half the patients will receive standard information. The study will look at the impact of the digital tool on patient activation, health related quality of life (HRQoL), health status, psychological distress, NHS resource utilisation and health care costs.
Details
| Lead sponsor | Royal Marsden NHS Foundation Trust |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 165 |
| Start date | Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Dec 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Breast Cancer
Interventions
- OWise
Countries
United Kingdom